ACE and coronary artery disorder: Thus, angiotensin-converting enzyme inhibitors (ACEIs) (44.9% vs. 48.1%, p = 0.385), angiotensin receptor blockers (ARBs) (4.1% vs. 9.6%, p = 0.314), or diuretics (34.7% vs. 53.8%, p = 0.822) were more frequently administered to patients in the second group, while beta-blockers (59.2% vs. 55.8%, p = 0.729) and aspirin (71.4% vs. 48.1%, p = 0.017) were more often recommended to patients in the first group (who more frequently associated CAD).